Albemarle Corporation (NYSE:ALB) – Equities researchers at Jefferies Group cut their Q3 2017 earnings per share (EPS) estimates for Albemarle Corporation in a research note issued to investors on Wednesday. Jefferies Group analyst L. Alexander now forecasts that the specialty chemicals company will earn $1.08 per share for the quarter, down from their previous forecast of $1.16. Jefferies Group has a “Buy” rating and a $120.00 price target on the stock. Jefferies Group also issued estimates for Albemarle Corporation’s Q4 2017 earnings at $1.04 EPS.

Other equities analysts have also issued research reports about the company. SunTrust Banks, Inc. lowered Albemarle Corporation from a “buy” rating to a “hold” rating and set a $121.00 price objective for the company. in a research note on Wednesday. Morgan Stanley reduced their price objective on Albemarle Corporation from $100.00 to $72.00 and set an “equal weight” rating for the company in a research note on Thursday, May 25th. Piper Jaffray Companies reiterated an “overweight” rating and set a $47.00 price objective on shares of Albemarle Corporation in a research note on Thursday, June 29th. Royal Bank Of Canada lifted their price objective on Albemarle Corporation from $132.00 to $136.00 and gave the company an “outperform” rating in a research note on Monday, May 8th. Finally, Nomura reiterated a “buy” rating and set a $124.00 price objective on shares of Albemarle Corporation in a research note on Friday, May 5th. Six equities research analysts have rated the stock with a hold rating, ten have issued a buy rating and one has assigned a strong buy rating to the company’s stock. Albemarle Corporation has an average rating of “Buy” and a consensus target price of $106.53.

TRADEMARK VIOLATION NOTICE: “Q3 2017 EPS Estimates for Albemarle Corporation Decreased by Jefferies Group (ALB)” was originally reported by Daily Political and is the property of of Daily Political. If you are accessing this news story on another domain, it was copied illegally and republished in violation of United States & international copyright legislation. The original version of this news story can be viewed at https://www.dailypolitical.com/2017/08/10/q3-2017-eps-estimates-for-albemarle-corporation-decreased-by-jefferies-group-alb.html.

Shares of Albemarle Corporation (NYSE:ALB) opened at 113.16 on Thursday. Albemarle Corporation has a 12-month low of $75.11 and a 12-month high of $123.48. The firm’s 50-day moving average price is $113.46 and its 200 day moving average price is $106.61. The company has a market cap of $12.53 billion, a price-to-earnings ratio of 27.50 and a beta of 1.59.

Albemarle Corporation (NYSE:ALB) last posted its quarterly earnings data on Monday, August 7th. The specialty chemicals company reported $1.13 EPS for the quarter, beating analysts’ consensus estimates of $1.11 by $0.02. The company had revenue of $737.25 million during the quarter, compared to analysts’ expectations of $735.50 million. Albemarle Corporation had a return on equity of 11.59% and a net margin of 31.49%. Albemarle Corporation’s revenue for the quarter was up 10.1% compared to the same quarter last year. During the same quarter in the prior year, the business earned $0.93 earnings per share.

The firm also recently announced a quarterly dividend, which will be paid on Monday, October 2nd. Stockholders of record on Friday, September 15th will be given a dividend of $0.32 per share. This represents a $1.28 dividend on an annualized basis and a dividend yield of 1.13%. The ex-dividend date of this dividend is Thursday, September 14th. Albemarle Corporation’s dividend payout ratio (DPR) is presently 16.41%.

In other news, Chairman Luther C. Iv Kissam sold 50,000 shares of the firm’s stock in a transaction dated Friday, July 7th. The stock was sold at an average price of $110.08, for a total transaction of $5,504,000.00. Following the sale, the chairman now directly owns 252,917 shares in the company, valued at approximately $27,841,103.36. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, CFO Scott Tozier sold 25,000 shares of the firm’s stock in a transaction dated Friday, July 7th. The shares were sold at an average price of $110.13, for a total value of $2,753,250.00. Following the sale, the chief financial officer now owns 57,506 shares in the company, valued at $6,333,135.78. The disclosure for this sale can be found here. Insiders have sold a total of 105,000 shares of company stock worth $11,499,850 over the last 90 days. Insiders own 0.74% of the company’s stock.

Several large investors have recently bought and sold shares of the stock. Bienville Capital Management LLC boosted its stake in Albemarle Corporation by 0.7% in the second quarter. Bienville Capital Management LLC now owns 6,750 shares of the specialty chemicals company’s stock worth $715,000 after buying an additional 45 shares during the period. AGF Investments America Inc. boosted its stake in Albemarle Corporation by 30.5% in the second quarter. AGF Investments America Inc. now owns 37,068 shares of the specialty chemicals company’s stock worth $3,912,000 after buying an additional 8,657 shares during the period. Synovus Financial Corp boosted its stake in Albemarle Corporation by 2.9% in the second quarter. Synovus Financial Corp now owns 10,482 shares of the specialty chemicals company’s stock worth $1,110,000 after buying an additional 292 shares during the period. Banque Pictet & Cie SA boosted its stake in Albemarle Corporation by 80.4% in the second quarter. Banque Pictet & Cie SA now owns 52,643 shares of the specialty chemicals company’s stock worth $5,556,000 after buying an additional 23,458 shares during the period. Finally, MUFG Securities EMEA plc acquired a new stake in Albemarle Corporation during the second quarter worth approximately $512,000. Hedge funds and other institutional investors own 85.39% of the company’s stock.

Albemarle Corporation Company Profile

Albemarle Corporation is a global developer, manufacturer and marketer of highly-engineered specialty chemicals. The Company operates through three segments: Lithium and Advanced Materials, Bromine Specialties and Refining Solutions. Lithium and Advanced Materials segment consist of two product categories: Lithium and Performance Catalyst Solutions.

Earnings History and Estimates for Albemarle Corporation (NYSE:ALB)

Receive News & Ratings for Albemarle Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Albemarle Corporation and related companies with MarketBeat.com's FREE daily email newsletter.